Categories

Industry News

Transasia Showcases Clinical Lab Solutions at APPI 2017

By Labmedica International staff writers
16 Jun 2017

Image: The Sysmex XN-330 hematology analyzer, one of three analyzers showcased at the APPI 2017 conference (Photo courtesy of Transasia).Transasia Bio-Medicals Ltd. (Mumbai, India), an in-vitro diagnostic company, will be the technology partner as well as principal partner of the 4th Annual Conference hosted by the Association of Practicing Pathologists of India (APPI-Mumbai), held June 16-18, 2017, in Mumbai, India.

Transasia, a part of the global Erba Diagnostics Mannheim GmbH Group, offers solutions and products in biochemistry, hematology, coagulation, ESR, immunology, urinalysis, critical care, diabetes management, microbiology and molecular diagnostics. During the three-day event, which will be attended by over 1,000 practicing pathologists from India and across the world, the company will introduce new products and processes that provide an end-to-end solution for improved lab efficiency. Transasia will be introducing Sysmex XN-330, the latest six-part differential hematology analyzer as well as showcasing the EM 200, a fully automated biochemistry analyzer, and the ECL 760 coagulation analyzer.

Additionally, Transasia will also organize interactive scientific sessions and workshops led by experienced industry veterans in the fields of hematology, biochemistry and coagulation. This will provide an important forum for practicing pathologists and lab owners to engage in a dialogue about critical compliance and operational challenges, as well as open the doors for further discussions on the best practice approaches for addressing those challenges.



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

15 Aug 2017
Philips Sells MR-HIFU Business to Profound Medical
Royal Philips has completed the sale of its Sonalleve MR-HIFU business to Profound Medical Inc.
Read More
07 Aug 2017
Philips Sells MR-HIFU Business to Profound Medical
Royal Philips has completed the sale of its Sonalleve MR-HIFU business to Profound Medical Inc.
Read More
07 Aug 2017
Mexico IVD Market Valued at USD 405 Million for 2016
Mexico's in vitro diagnostic (IVD) market is valued at USD 405 million for 2016, making it the second largest in Latin America, and is considered moderate in its regulatory process and foreign investment opportunities. These are the latest findings of Kalorama Information, an independent medical market research firm.
Read More
01 Aug 2017
DiaSorin to Acquire Siemens' ELISA Immunodiagnostics Business
DiaSorin S.p.A. has entered into an agreement to acquire Siemens Healthineers’ micro-titre-based ELISA immunodiagnostic business portfolio and related tangible and intangible assets, including customer sales and distribution contracts, installed base of instruments and relevant intellectual property.
Read More
24 Jul 2017
Siemens to Acquire Blood Gas Subsidiary of Alere
Siemens Healthineers, the separately managed healthcare business of Siemens AG, has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. that develops and provides point-of-care (POC) blood diagnostic systems for healthcare enterprises.
Read More
24 Jul 2017
Quidel to Acquire Alere Triage Assets
Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, has entered into definitive agreements to acquire the Triage MeterPro cardiovascular (CV) and toxicology assets (“Triage business”) and the B-type Naturietic Peptide (BNP) assay business run on Beckman Coulter analyzers (“BNP business”) from Alere Inc. These products are being divested in order to obtain antitrust approvals required for Abbott’s pending acquisition of Alere.
Read More
24 Jul 2017
Philips Acquires TomTec Imaging Systems
Royal Philips has signed an agreement to acquire TomTec Imaging Systems GmbH, a provider of intelligent image analysis software, especially for diagnostic ultrasound. The acquisition is expected to strengthen Philips’ position in cardiac ultrasound, and support the company’s further expansion in other clinical areas, such as obstetrics and gynecology (OB/GYN).
Read More
17 Jul 2017
Global Clinical Lab Services Market to Reach USD 327 Billion by 2025
The global clinical laboratory services market is expected to reach USD 327 billion by 2025, driven by the improvement and implementation of informatics and automated data management solutions to perform seamless operations. The competition among medical device manufacturers for the development of clinical chemistry analyzers that can provide rapid results is also expected to aid the market growth. However, sample preparation and running it through experimental protocols with enhanced productivity still remains a challenge for labs.
Read More
11 Jul 2017
Global Hematology Analyzer Market to Surpass USD 2 Billion by 2024
The global hematology analyzer market is expected to surpass USD 2 billion, driven by the introduction of new and innovative products & methods, with sales of 6-part differential analyzers to register the fastest growth and hospitals to account for the highest share.
Read More
Copyright © 2000-2017 TradeMed.com. All rights reserved. | Terms And Conditions